Duffull, Stephen
Duffull, Stephen
Потвърден имейл адрес: otago.ac.nz - Начална страница
Quantification of lean bodyweight
S Janmahasatian, SB Duffull, S Ash, LC Ward, NM Byrne, B Green
Clinical pharmacokinetics 44 (10), 1051-1065, 2005
Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
MS Salahudeen, SB Duffull, PS Nishtala
BMC geriatrics 15 (1), 1-14, 2015
What is the best size descriptor to use for pharmacokinetic studies in the obese?
B Green, SB Duffull
British journal of clinical pharmacology 58 (2), 119-133, 2004
Impaired nitric oxide bioavailability and l-arginine–reversible endothelial dysfunction in adults with falciparum malaria
TW Yeo, DA Lampah, R Gitawati, E Tjitra, E Kenangalem, YR McNeil, ...
The Journal of experimental medicine 204 (11), 2693-2704, 2007
Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria
TW Yeo, DA Lampah, R Gitawati, E Tjitra, E Kenangalem, K Piera, ...
Proceedings of the National Academy of Sciences 105 (44), 17097-17102, 2008
Dosing in obesity: a simple solution to a big problem
PY Han, SB Duffull, CMJ Kirkpatrick, B Green
Clinical Pharmacology & Therapeutics 82 (5), 505-508, 2007
A suggested approach to once‐daily aminoglycoside dosing.
EJ Begg, ML Barclay, SB Duffull
British journal of clinical pharmacology 39 (6), 605-609, 1995
A systematic review and meta‐analysis of pharmacist‐led fee‐for‐services medication review
E Hatah, R Braund, J Tordoff, SB Duffull
British journal of clinical pharmacology 77 (1), 102-115, 2014
Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram
A Chan, GK Isbister, CMJ Kirkpatrick, SB Dufful
QJM: An International Journal of Medicine 100 (10), 609-615, 2007
Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs
S Retout, S Duffull, F Mentré
Computer methods and Programs in Biomedicine 65 (2), 141-151, 2001
Clinical pharmacokinetics and dose optimisation of carboplatin
SB Duffull, BA Robinson
Clinical pharmacokinetics 33 (3), 161-183, 1997
Red blood cell survival in long-term dialysis patients
FE Vos, JB Schollum, CV Coulter, TCA Doyle, SB Duffull, RJ Walker
American journal of kidney diseases 58 (4), 591-598, 2011
Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria
TW Yeo, DA Lampah, E Tjitra, R Gitawati, E Kenangalem, K Piera, ...
The Journal of infectious diseases 200 (10), 1522-1529, 2009
Studying drugs in human milk: time to unify the approach
EJ Begg, SB Duffull, LP Hackett, KF Ilett
Journal of Human Lactation 18 (4), 323-332, 2002
Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia
BA Atcheson, PJ Taylor, CMJ Kirkpatrick, SB Duffull, DW Mudge, ...
Therapeutic drug monitoring 26 (3), 284-286, 2004
A comprehensive model for the humoral coagulation network in humans
T Wajima, GK Isbister, SB Duffull
Clinical Pharmacology & Therapeutics 86 (3), 290-298, 2009
A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin
CS Zin, LM Nissen, JP O'Callaghan, SB Duffull, MT Smith, BJ Moore
The Journal of Pain 11 (5), 462-471, 2010
Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring
FE Vos, JB Schollum, CV Coulter, PJ Manning, SB Duffull, RJ Walker
Nephrology 17 (2), 182-188, 2012
Interpreting population pharmacokinetic‐pharmacodynamic analyses–a clinical viewpoint
SB Duffull, DFB Wright, HR Winter
British journal of clinical pharmacology 71 (6), 807-814, 2011
Development of a dosing strategy for enoxaparin in obese patients
B Green, SB Duffull
British journal of clinical pharmacology 56 (1), 96-103, 2003
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20